Contract Service Directory


Exelead





Company Headquarters

6925 Guion Road
Indianapolis, IN 46268
United States

Company Description

Exelead is a CDMO dedicated to the development and commercialization of therapeutics to treat life-threatening diseases. Exelead’s core technologies focus on the manufacture of sterile drug products specializing in liposomal and PEGylation formulation technologies. Exelead has development capabilities that can be utilized to improve drug delivery and drug product characterization. The Indianapolis, Indiana manufacturing facility produces proprietary parenteral pharmaceuticals for oncology and enzyme replacement treatment, as well as for the treatment of numerous infectious diseases. Our staff is a balance of: chemists, chemical engineers, microbiologists, and pharmaceutical manufacturing experts. Senior Exelead management is a mix of seasoned executives from the pharmaceutical and biotechnology industries. Exelead is a wholly owned subsidiary of Essetefin SpA (Rome, Italy) and is led by John Rigg, Vice President and General Manager.

Contract Service Directory

    Related Content

    • Breaking News | Collaborations & Alliances | Supply Chain
      Schreiner MediPharm, PragmatIC Form Partnership for Smart Pharma Labels

      Schreiner MediPharm, PragmatIC Form Partnership for Smart Pharma Labels

      New RFID-labels ideal for broad array of pharmaceutical products and medical devices.
      Schreiner MediPharm 12.11.19

    • Drug Development | Drug Discovery

    • APIs | cGMP Manufacture | Drug Development | Formulation Development
      Contract Pharma’s 20th Anniversary Series: Small Molecules

      Contract Pharma’s 20th Anniversary Series: Small Molecules

      Matthew Moorcroft of Cambrex discusses the impact of pharmaceutical industry trends for small molecules and CDMOs
      Kristin Brooks, Contract Pharma 11.05.19


    • Federal Equipment

      Federal Equipment's Adam Covitt

      Federal Equipment's vice president was on hand at Contract Pharma 2019.

    • AAPS Event Info

      AAPS Event Info

      ...
      10.28.19

    • Breaking News | Drug Development | Industry News
      AbbVie Enters Strategic Cystic Fibrosis Alliance

      AbbVie Enters Strategic Cystic Fibrosis Alliance

      To develop a cystic fibrosis transmembrane conductance regulator compound licensed from the Cystic Fibrosis Foundation
      10.24.19


    • Drug Delivery | Industry News
      CURE Pharmaceutical Expands Oral Drug Delivery Product Line

      CURE Pharmaceutical Expands Oral Drug Delivery Product Line

      To expand manufacturing footprint by 50%, adding new blending, casting and packaging equipment in Oxnard, CA
      10.09.19

    • Breaking News | Industry News
      VIDEO: Federal Equipment

      VIDEO: Federal Equipment's Adam Covitt

      Federal Equipment's vice president was on hand at Contract Pharma 2019.
      10.02.19

    • Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
      Catalent, Acura Enter Clinical Manufacturing Pact

      Catalent, Acura Enter Clinical Manufacturing Pact

      Catalent to scale-up manufacturing of LTX-03 for clinical testing
      09.16.19


    • cGMP Manufacture | Clinical Trial Materials | Industry News
      Rentschler Biopharma Takes on New Projects at Milford, MA Facility

      Rentschler Biopharma Takes on New Projects at Milford, MA Facility

      The site will support both clinical and commercial manufacturing programs
      09.04.19

    • Breaking News | Collaborations & Alliances | Industry News | Information Technology | Injectables
      Nephron, Clemson Collaborate on Syringe-Filling Automation

      Nephron, Clemson Collaborate on Syringe-Filling Automation

      The robotic solution aims to enhance sterile manufacturing in the pharmaceutical production process
      08.14.19

    • Advanced Clinical Opens New Office in Italy

      Advanced Clinical Opens New Office in Italy

      Company now able to serve clients in all major markets throughout Western Europe
      08.13.19


    • Biologics, Proteins, Vaccines | Drug Delivery | Injectables
      Growth in Biologics and Maintaining Patient Satisfaction

      Growth in Biologics and Maintaining Patient Satisfaction

      Vicki A. Barbur of Battelle discusses the driving forces for biologics, the challenges, and new delivery methods
      Kristin Brooks, Contrct Pharma 08.09.19

    • Trials & Filings
      La Jolla Pharma Receives Orphan Designation for Malaria Treatment

      La Jolla Pharma Receives Orphan Designation for Malaria Treatment

      LJPC-0118, artesunate, demonstrated to be superior to quinine in reducing mortality in patients with falciparum malaria infection
      07.23.19

    • Breaking News | Industry News | Logistics | Packaging & Tracking
      Marken Acquires Three European Logistics Companies

      Marken Acquires Three European Logistics Companies

      Expands logistics footprint in Italy, Austria and Hungary
      07.15.19

    • Breaking News | Facilities | Fill/Finish | Industry News
      Catalent Breaks Ground in Indiana

      Catalent Breaks Ground in Indiana

      $112 million drug product manufacturing facility will increase fill/finish capacity by 79,000 sq. ft.
      07.15.19